Aska Pharmaceutical News and Activities
Presence
Aska Pharmaceutical develops, manufactures, and sells prescription medicines and healthcare products. Its main offerings include therapies for women's health, urology, and endocrinology for hospitals, clinics, and other medical providers.
Aska Pharmaceutical products and services overview:
- Prescription medicines
- Womens health drugs
- Urology treatments
- Endocrine therapies
- Animal health products
Revenue: ~$480 million
Employees: 1,300
Headquarters: Tokyo, Japan
Aska Pharmaceutical is one of the...
Aska Pharmaceutical is a company listed under the stock ticker 4886 (JP).
Executives
View the org chart displaying its 14 main executives
Most searched biographies at Aska Pharmaceutical
- Takashi Yamaguchi, President and Representative Director
- Maiko Mori, Member of the Board of Directors
- Yasuji Enokido, Director
Create your alert
to follow the executive moves at Aska Pharmaceutical.
Pharmaceuticals
Aska Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Aska Pharmaceutical
Social media about Aska Pharmaceutical
- Aska Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Aska Pharmaceutical on LinkedIn, X (Twitter) & YouTube
